Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee

Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term

Alembic Pharma receives USFDA approval for Haloperidol tablets

The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical

Suven Life reports positive interim review for phase 3 Alzheimer’s therapy

Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial

Glenmark launches generic Lacosamide Injection USP in US Market

Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually

CORONA Remedies spearheads green footprint campaign on World Environment Day

The company recycled approximately 100 kilograms of textile waste, undertook plantation activities, and encouraged employees to adopt environmentally responsible practices

Wanbury FY26 PAT surges 117% to Rs. 66.1 crore

Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS

Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness

Ipca Laboratories appoints Dr. Sandarbh Rishi as Head – MSAT/Pilot Plant

Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations

Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business

Juneja brings more than three decades of experience in pharmaceutical sales and marketing

Akums secures European CEP approval for Cefpodoxime Proxetil

The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner